John M. Lindlof

Array ( [id] => 4205001 [patent_doc_number] => 06027876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Method for monitoring pesticide resistance' [patent_app_type] => 1 [patent_app_number] => 7/998289 [patent_app_country] => US [patent_app_date] => 1992-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 2 [patent_no_of_words] => 12377 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027876.pdf [firstpage_image] =>[orig_patent_app_number] => 998289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3097480 [patent_doc_number] => 05314803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'Process and test carrier for the determination of an enzyme from an isoenzyme mixture' [patent_app_type] => 1 [patent_app_number] => 7/989875 [patent_app_country] => US [patent_app_date] => 1992-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/314/05314803.pdf [firstpage_image] =>[orig_patent_app_number] => 989875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3415168 [patent_doc_number] => 05433945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Immunoprotective genetically-detoxified mutants of pertussis toxin' [patent_app_type] => 1 [patent_app_number] => 7/979798 [patent_app_country] => US [patent_app_date] => 1992-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 37 [patent_no_of_words] => 14181 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/433/05433945.pdf [firstpage_image] =>[orig_patent_app_number] => 979798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456506 [patent_doc_number] => 05441736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/971558 [patent_app_country] => US [patent_app_date] => 1992-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11897 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441736.pdf [firstpage_image] =>[orig_patent_app_number] => 971558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949101 [patent_doc_number] => 05998577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Method for determining mimotopes' [patent_app_type] => 1 [patent_app_number] => 7/968366 [patent_app_country] => US [patent_app_date] => 1992-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 6869 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998577.pdf [firstpage_image] =>[orig_patent_app_number] => 968366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2973682 [patent_doc_number] => 05204015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-20 [patent_title] => 'Subtilisin mutants' [patent_app_type] => 1 [patent_app_number] => 7/958885 [patent_app_country] => US [patent_app_date] => 1992-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 10 [patent_no_of_words] => 8507 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/204/05204015.pdf [firstpage_image] =>[orig_patent_app_number] => 958885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560877 [patent_doc_number] => 05525513 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'DNA encoding the heme-regulated eukaryotic initiation factor 2.alpha. kinase' [patent_app_type] => 1 [patent_app_number] => 7/938782 [patent_app_country] => US [patent_app_date] => 1992-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8969 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525513.pdf [firstpage_image] =>[orig_patent_app_number] => 938782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3021359 [patent_doc_number] => 05288846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-22 [patent_title] => 'Cell specific gene regulators' [patent_app_type] => 1 [patent_app_number] => 7/924396 [patent_app_country] => US [patent_app_date] => 1992-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8567 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/288/05288846.pdf [firstpage_image] =>[orig_patent_app_number] => 924396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3092597 [patent_doc_number] => 05292646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-08 [patent_title] => 'Peptide and protein fusions to thioredoxin and thioredoxin-like molecules' [patent_app_type] => 1 [patent_app_number] => 7/921848 [patent_app_country] => US [patent_app_date] => 1992-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 7 [patent_no_of_words] => 12921 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/292/05292646.pdf [firstpage_image] =>[orig_patent_app_number] => 921848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2996070 [patent_doc_number] => 05358862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Synthetic TRNAS' [patent_app_type] => 1 [patent_app_number] => 7/914212 [patent_app_country] => US [patent_app_date] => 1992-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10452 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358862.pdf [firstpage_image] =>[orig_patent_app_number] => 914212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3489017 [patent_doc_number] => 05439815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'Restrictocin-like ribotoxin analogues comprising only one cysteine available for covalent linkage to a partner' [patent_app_type] => 1 [patent_app_number] => 7/912740 [patent_app_country] => US [patent_app_date] => 1992-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11811 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/439/05439815.pdf [firstpage_image] =>[orig_patent_app_number] => 912740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3029821 [patent_doc_number] => 05317085 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-31 [patent_title] => 'Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response' [patent_app_type] => 1 [patent_app_number] => 7/909644 [patent_app_country] => US [patent_app_date] => 1992-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 15068 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/317/05317085.pdf [firstpage_image] =>[orig_patent_app_number] => 909644 [rel_patent_id] =>[rel_patent_doc_number] =>)